← FDA Drug Approvals (Drugs@FDA)

LEVOFLOXACIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2010-12-20

Drug application

FDA Application #
ANDA090268
Application type
Abbreviated New Drug Application (Generic)
Brand name
LEVOFLOXACIN
Generic name
Levofloxacin
Active ingredients
LEVOFLOXACIN
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Discontinued
Sponsor
SCIEGEN PHARMS
First approval
2010-12-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown